XML 45 R31.htm IDEA: XBRL DOCUMENT v3.6.0.2
Business Acquisition (Tables)
12 Months Ended
Dec. 31, 2016
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
The following table summarizes the allocation of the purchase consideration as follows (in thousands):
Assets and Liabilities
Valuation
 
 
Accounts receivable
$
18,024

Other assets
 
5,500

Property and equipment
 
10,022

Deferred tax asset
 
419

Software
 
9,836

Trade names
 
28,192

Customer relationships
 
98,498

Other intangibles
 
2,121

Goodwill
 
184,837

Accounts payables and accrued expenses
 
(14,338
)
Deferred revenue
 
(29,182
)
Deferred tax liability
 
(12,328
)
Capital lease
 
(1,361
)
           Total
$
300,240

The following table summarizes the allocation of the purchase consideration for all 2016 acquisitions (in thousands):
Assets and Liabilities (1)
Valuation
 
 
Accounts receivable
$
70,922

Other assets
 
11,730

Property and equipment
 
11,109

Trade names
 
5,866

Trademarks
 
70,300

Customer relationships
 
85,482

Other intangibles
 
91,264

Goodwill
 
333,190

Accounts payables and accrued expenses
 
(62,188
)
Deferred revenue
 
(6,904
)
Deferred tax liability
 
(14,503
)
Capital lease
 
(194
)
           Total
$
596,074

The following table summarizes the allocation of the purchase consideration as follows (in thousands):
Assets and Liabilities
Valuation
 
 
Accounts receivable
$
14,935

Other assets
 
1,415

Property and equipment
 
5,769

Software
 
18,764

Trade names
 
22,602

Customer relationships
 
98,027

Other intangibles
 
1,873

Goodwill
 
172,593

Accounts payables and accrued expenses
 
(9,684
)
Deferred revenue
 
(10,764
)
Deferred tax liability
 
(1,316
)
Capital lease
 
(195
)
           Total
$
314,019

Business Acquisition, Pro Forma Information [Table Text Block]
The supplemental information on an unaudited pro forma financial basis presents the combined results of j2 Global and its 2015 acquisitions as if each acquisition had occurred on January 1, 2014 (in thousands, except per share amounts):
 
Year ended
 
December 31,
2015
 
December 31,
2014
 
(unaudited)
 
(unaudited)
Revenues
$
823,904

 
$
744,388

Net income
$
159,408

 
$
126,196

EPS - Basic
$
3.29

 
$
2.64

EPS - Diluted
$
3.26

 
$
2.62

The supplemental information on an unaudited pro forma financial basis presents the combined results of j2 Global and its 2016 acquisitions as if each acquisition had occurred on January 1, 2015 (in thousands, except per share amounts):
 
Year ended
 
December 31,
2016
 
December 31,
2015
 
(unaudited)
 
(unaudited)
Revenues
$
1,102,510

 
$
1,009,169

Net income
$
108,822

 
$
11,817

EPS - Basic
$
2.25

 
$
2.31

EPS - Diluted
$
2.24

 
$
2.29

The supplemental information on an unaudited pro forma financial basis presents the combined results of j2 Global and its 2014 acquisitions as if each acquisition had occurred on January 1, 2013 (in thousands, except per share amounts):
 
Year ended
 
December 31,
2014
 
December 31,
2013
 
(unaudited)
 
(unaudited)
Revenues
$
672,701

 
$
626,906

Net income
$
119,773

 
$
132,480

EPS - Basic
$
2.51

 
$
2.85

EPS - Diluted
$
2.49

 
$
2.81

EVDY [Member]  
Business Acquisition [Line Items]  
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed [Table Text Block]
The following table summarizes the allocation of the purchase consideration for the Everyday Health acquisition (in thousands):
Assets and Liabilities
Valuation
 
 
Cash
$
15,918

Accounts receivable
 
67,968

Other assets
 
11,168

Property and equipment
 
6,494

Trademarks
 
70,300

Customer relationships
 
45,500

Other intangibles
 
88,267

Goodwill
 
263,988

Accounts payables and accrued expenses
 
(59,091
)
Deferred revenue
 
(5,297
)
Deferred tax liability
 
(11,500
)
           Total
$
493,715

Business Acquisition, Pro Forma Information [Table Text Block]

The supplemental information on an unaudited pro forma financial basis presents the combined results of j2 Global and Everyday Health as if the acquisition had occurred on January 1, 2015 (in thousands, except per share amounts):
 
Year ended
 
December 31,
2016
 
December 31,
2015
 
(unaudited)
 
(unaudited)
Revenues
$
1,082,813

 
$
952,806

Net income
$
103,541

 
$
115,059

EPS - Basic
$
2.14

 
$
2.38

EPS - Diluted
$
2.13

 
$
2.35